Amy C. Peterson, CMO, Immuno-oncology at BeiGene, Ltd. (BGNE), sold 7,202 shares at $82.79 ($598K) on 2017-11-13, disclosed to the SEC on 2017-11-15.
Open-market sale of $598k BGNE by CMO, Immuno-oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.79 | 2,400 | $199K | 33.3% |
| 2 | $82.79 | 2,400 | $199K | 33.3% |
| 3 | $83.31 | 1,201 | $100K | 16.7% |
| 4 | $83.31 | 1,201 | $100K | 16.7% |
| Total | $82.96 avg | 7,202 | $598K | 100% |
| Filing → |
| CTMX | SELL | 2022-07-21 | $11K | — | Filing → |
| BGNE | SELL | 2018-12-19 | $4.5M | — | Filing → |
| BGNE | SELL | 2018-11-13 | $8.8M | — | Filing → |